1) Keys A. Seven Countries. A multivariate analysis of death and coronary heart disease. Cambridge. MA: Harvard University Press; 1980
|
|
|
2) Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb. 2007; 14: 278-86
|
|
|
3) Okamura T, Tanaka H, Miyamatsu N, et al. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17. 3 year study of a Japanese cohort. Atherosclerosis. 2007; 190: 216-23
|
|
|
4) Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths. Lancet. 2007; 370; 1829-39
|
|
|
5) Zhang X, Patel A, Horibe H, et al. Asia Pacific Cohort Studies Collaboration. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003; 32: 563-72
|
|
|
6) NIPPON DATA80 Research Group. Risk asses-sment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J. 2006; 70: 1249-55
|
|
|
7) Wilson PWF, DʼAgostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837-47
|
|
|
8) Okamura T, Kokubo Y, Watanabe M, et al. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis. 2009; 203: 587-92
|
|
|
9) Imamura T, Doi Y, Arima H, et al. LDL cho-lesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke. 2009; 40: 382-8
|
|
|
10) Imano H, Noda H, Kitamura A, et al. Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Prev Med. 2011; 52: 381-6
|
|
|
11) Tanno K, Okamura T, Ohsawa M, et al. Com-parison of low-density lipoprotein cholesterol concentrations measured by a direct homogeneous assay and by the Friedewald formula in a large community population. Clin Chim Acta. 2010; 411: 1774-80
|
|
|
12) Kitamura A, Noda H, Nakamura M, et al. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb. 2011; 18: 454-63
|
|
|
13) Tanabe N, Iso H, Okada K, et al. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events - the JALS-ECC -. Circ J. 2010; 74: 1346-56
|
|
|
14) Amarenco P. The paradox of cholesterol and stroke. Lancet. 2007; 370: 1803-4
|
|
|
15) Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989; 320: 904-10
|
|
|
16) Soyama Y, Miura K, Morikawa Y, et al. High-density lipoprotein cholesterol and the risk of stroke in Japanese men and women: the Oyabe study. Stroke. 2003; 34: 863-8
|
|
|
17) Noda H, Iso H, Irie F, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation. 2009; 119: 2136-45
|
|
|
18) Okamura T. Low blood cholesterol and intrapa-renchymal hemorrhage in cohort studies. J Atheroscler Thromb. 2010; 17: 312-4
|
|
|